CoNCERT Pharmaceuticals: ROTH Conference (Concert Pharma) - Mar 11, 2014 - Anticipated data from P2 trial for diabetic kidney disease by YE 2014; Anticipated completion of P2 open-label trial for diabetic kidney disease by YE 2014
Anticipated P2 data • Anticipated trial completion date • Renal Disease
|